Annual Revenue Comparison: Bio-Techne Corporation vs TG Therapeutics, Inc.

Biotech Revenue Trends: Bio-Techne vs. TG Therapeutics

__timestampBio-Techne CorporationTG Therapeutics, Inc.
Wednesday, January 1, 2014357763000152381
Thursday, January 1, 2015452246000152381
Friday, January 1, 2016499023000152381
Sunday, January 1, 2017563003000152381
Monday, January 1, 2018642993000152000
Tuesday, January 1, 2019714006000152000
Wednesday, January 1, 2020738691000152000
Friday, January 1, 20219310320006689000
Saturday, January 1, 202211055990002785000
Sunday, January 1, 20231136702000233662000
Monday, January 1, 20241159060000
Loading chart...

Cracking the code

A Tale of Two Biotech Companies: Revenue Trends from 2014 to 2023

In the dynamic world of biotechnology, revenue growth is a key indicator of a company's success and market influence. Over the past decade, Bio-Techne Corporation has demonstrated a robust upward trajectory, with its annual revenue surging by over 220% from 2014 to 2023. This growth reflects Bio-Techne's strategic innovations and market expansion.

Conversely, TG Therapeutics, Inc. has experienced a more volatile revenue pattern. After years of modest earnings, TG Therapeutics saw a dramatic spike in 2023, with revenue increasing by an astonishing 8,000% compared to 2022. This leap suggests a significant breakthrough or market shift, although data for 2024 remains unavailable.

These contrasting revenue paths highlight the diverse challenges and opportunities within the biotech sector, offering valuable insights for investors and industry analysts alike.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025